Literature DB >> 18276166

Elective shoulder arthroplasty in patients older than ninety years of age.

R Sean Churchill1.   

Abstract

This study examined the outcome of elective shoulder arthroplasty for glenohumeral osteoarthritis or rotator cuff arthropathy in patients aged older than 90 years. The study included 7 shoulders in 6 patients with an average age of 93 years 5 months, (range, 91 years 0 months to 97 years 4 months). Average follow-up was 2.2 years, (range, 1-4 years). Preoperative range of motion, Simple Shoulder Test (SST) scores, and Medical Outcomes Study Short-Form 36-Item Health Survey (SF-36) scores were obtained and compared with postoperative values at 3 and 6 months and yearly thereafter. Average forward elevation improved from 87 degrees to 137 degrees (P < .00001), and external rotation to the side improved from 0 degrees to 50 degrees (P < .0001). The SST scores improved from a preoperative average of 2.0 to 6.1 at 3 months (P < .0001), 6.9 at 6 months (P < .0001), 8.0 at 1 year (P < .00001), and 7.4 at 2 years (P < .0001). Significant improvements occurred in 6 of 8 SF-36 domains: Mental Health (P < .05), Vitality (P < .01), Role limitations due to emotional problems (P < .05), Social Function (P < .001), Role limitations due to physical health (P < .001), and Comfort (P < .00001). No patient had worse pain or function postoperatively. These data suggest that elective shoulder arthroplasty can be performed in patients 90 years of age and older, providing excellent pain relief, improved functional outcome, and enhanced general health status.

Entities:  

Mesh:

Year:  2008        PMID: 18276166     DOI: 10.1016/j.jse.2007.09.005

Source DB:  PubMed          Journal:  J Shoulder Elbow Surg        ISSN: 1058-2746            Impact factor:   3.019


  7 in total

1.  Total shoulder arthroplasty in older patients: increased perioperative morbidity?

Authors:  Eric T Ricchetti; Joseph A Abboud; Andrew F Kuntz; Matthew L Ramsey; David L Glaser; Gerald R Williams
Journal:  Clin Orthop Relat Res       Date:  2011-04       Impact factor: 4.176

2.  CORR Insights®: What Are the Complications, Survival, and Outcomes After Revision to Reverse Shoulder Arthroplasty in Patients Older Than 80 Years?

Authors:  Aaron M Chamberlain
Journal:  Clin Orthop Relat Res       Date:  2019-09       Impact factor: 4.176

3.  What Are the Complications, Survival, and Outcomes After Revision to Reverse Shoulder Arthroplasty in Patients Older Than 80 Years?

Authors:  Eduard Alentorn-Geli; Nicholas J Clark; Andrew T Assenmacher; Brian T Samuelsen; Joaquín Sánchez-Sotelo; Robert H Cofield; John W Sperling
Journal:  Clin Orthop Relat Res       Date:  2017-07-11       Impact factor: 4.176

4.  Anatomic shoulder replacement for primary osteoarthritis in patients over 80 years: outcome is as good as in younger patients.

Authors:  Iker Iriberri; Christian Candrian; Michael T Freehill; Patric Raiss; Pascal Boileau; Gilles Walch
Journal:  Acta Orthop       Date:  2015-01-14       Impact factor: 3.717

5.  Serious adverse events and lifetime risk of reoperation after elective shoulder replacement: population based cohort study using hospital episode statistics for England.

Authors:  Richard S Craig; Jennifer C E Lane; Andrew J Carr; Dominic Furniss; Gary S Collins; Jonathan L Rees
Journal:  BMJ       Date:  2019-02-20

6.  Few geographic and socioeconomic variations exist in primary total shoulder arthroplasty: a multi-level study of Australian registry data.

Authors:  Sharon L Brennan-Olsen; Richard S Page; Stephen E Lane; Michelle Lorimer; Rachelle Buchbinder; Richard H Osborne; Julie A Pasco; Anita E Wluka; Kerrie M Sanders; Peter R Ebeling; Stephen E Graves
Journal:  BMC Musculoskelet Disord       Date:  2016-07-16       Impact factor: 2.362

7.  Comparison of 90-Day Perioperative Outcomes in Shoulder Arthroplasty Between the Elderly and Nonelderly Patients.

Authors:  Paul D Crook; William C Foster; Stephen L Kates; Jonathan R Korpon; Gustavo A Ortega; Douglas N Boardman
Journal:  Geriatr Orthop Surg Rehabil       Date:  2018-10-25
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.